市場調查報告書
商品編碼
1439330
輸尿管鏡 - 全球市場回顧、競爭格局、市場預測 (2030)Ureteroscope - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
全球輸尿管鏡市場規模預計到2023年將達到9億美元,到2030年將達到12.4億美元,2024-2030年預測期間複合年增長率為5.49%。輸尿管鏡檢查的需求增加可能是由於肥胖負擔增加導致尿路結石或腎結石盛行率增加,而肥胖是腎結石形成的危險因子。此外,久坐的生活方式、產品設計的創新和新產品的推出也是促進市場成長的因素。
輸尿管鏡市場動態
近年來,由於全球泌尿道結石盛行率不斷上升,輸尿管鏡檢查的發展勢頭強勁。根據歐洲泌尿外科協會European Association of Urology(2019)的數據,尿路結石的盛行率從 1% 到 20% 不等,生活水準高的國家,如加拿大、瑞典和美國,腎結石的盛行率較低結石,相當高(超過10%)。
此外,久坐的生活方式增加,例如過量飲酒和減少液體攝取量,也可能導致腎結石的形成。此外,由於不良飲食習慣和缺乏運動等久坐的生活方式,肥胖是腎結石形成的高風險因素,肥胖負擔的增加也可能促進輸尿管鏡市場的成長。根據世界衛生組織(WHO)(2022)的數據,2016年全球肥胖人數約6.5億。此外,各種研究(包括Poore W.等人於2020年在NCBI發表的《肥胖及其對腎結石形成的影響》 "Obesity and Its Impact on Kidney Stone Formation" )表明,肥胖者更容易形成尿酸結石和草酸鈣結石。這種情況經常發生。
因此,上述因素預計將促進全球輸尿管鏡市場的成長。
然而,能夠在醫療環境中使用輸尿管鏡的熟練工人數量有限以及輸尿管鏡的高昂成本預計將對輸尿管鏡市場的成長構成挑戰。
輸尿管鏡市場區隔分析
在輸尿管鏡產品領域,輸尿管軟鏡預計在預測期內將佔據最大的市場份額。這是因為輸尿管軟鏡廣泛應用於各種腎結石和輸尿管結石的治療。此外,由於與半剛性輸尿管鏡相比,柔性輸尿管鏡是最新一代設備,因此它們對患者造成的疼痛和不適較少,且不太可能造成傷害。輸尿管軟鏡相對於半硬性輸尿管鏡的優勢將使患者需求轉向輸尿管軟鏡,擴大輸尿管軟鏡市場。此外,醫院輸尿管軟鏡的增加也是輸尿管軟鏡市場的驅動因素。例如,輸尿管軟鏡與雷射碎石術一起被泌尿科醫生廣泛應用於幾乎所有醫院,以更好地治療泌尿系結石,成功率高,併發症率低。此外,逆行性輸尿管軟鏡(RFU)在診斷尿路上皮癌方面具有較高的敏感性。
因此,上述因素可望帶動輸尿管軟鏡市場的發展。
預計北美將主導整個輸尿管鏡市場
在所有地區中,北美預計將主導整個輸尿管鏡市場。這一優勢得益於該地區有利的報銷方案、先進的醫療基礎設施以及上尿路結石疾病手術和醫療管理的詳細指南,預計將推動輸尿管鏡市場的發展。
此外,美國上泌尿道尿路上皮癌(UTUC)病例數的增加也是輸尿管鏡檢查使用增加的原因之一。例如,根據美國疾病管制與預防中心 (CDC) 的數據 (2020),美國約有 17,500 名女性和 56,000 名男性患有膀胱癌。此外,根據加拿大癌症協會 Canadian cancer society (2020) 的數據,2020 年約有 12,200 名加拿大人患有膀胱癌。
此外,該地區新產品的推出可能會推動該地區輸尿管鏡市場的發展。例如,2019 年,多尼爾醫療科技Dornier Medtech宣佈在美國推出並立即上市新型 AXIS 一次性數位輸尿管軟鏡。因此,這些因素預計將在預測期內對輸尿管鏡市場做出貢獻。
本報告提供了全球輸尿管鏡市場的研究和分析,包括市場規模和預測、驅動因素和挑戰、公司和產品概況。
Ureteroscope Market By Product Type (Flexible Ureteroscope [Digital Ureteroscope and Fiber Optic Ureteroscope], Semi-Rigid Ureteroscope), By Channel Type (Dual Channel and Single Channel), By Usability (Single-Use and Reusable), By Application (Urolithiasis, Urothelium Cancer, Urinary Strictures), By End-User (Hospitals, Ambulatory Surgical Centers, and Others), By Geography, is expected to grow at a constant CAGR forecast till 2030 due to the growing prevalence of urolithiasis among the population and technological advancement in the product portfolio.
The global ureteroscope market was valued at USD 0.90 billion in 2023, growing at a CAGR of 5.49% during the forecast period from 2024 to 2030, to reach USD 1.24 billion by 2030. The rise in demand for ureteroscope can be due to the growing prevalence of urolithiasis or nephrolithiasis accompanied by the rising burden of obesity which is a risk factor for development of kidney stones. In addition, sedentary lifestyle, innovation in product design, and new product launches among others are the factors responsible for the global market growth of ureteroscope.
Ureteroscope Market Dynamics:
Ureteroscope is gaining momentum in recent years owing to the rising prevalence of urolithiasis across the globe. According to the European Association of Urology 2019, the prevalence rates for urinary stones vary from 1% to 20%, and in the countries with a high standard of life such as Canada, Sweden, or the US, renal stones prevalence is significantly high (>10%).
Moreover, a rise in sedentary lifestyle such as excessive consumption of alcohol, less consumption of water could also lead to the development of kidney stones. In addition, the growing burden of obesity among the population, a high-risk factor for the development of renal calculi, due to sedentary lifestyles such as poor dietary habits and lack of physical activities could also contribute to the ureteroscope market growth. As per the World Health Organization (WHO) 2022 data, there was around 650 million obese population worldwide in the year 2016. Also, according to various studies (one of them being "Obesity and Its Impact on Kidney Stone Formation" by Poore W. et al., published in the NCBI in the year 2020) obese people develop more uric acid stones and calcium oxalate stones.
Thus, the aforementioned factors are anticipated to augment the global ureteroscope market growth.
However, certain factors such as the limited availability of a skilled workforce to utilise the device in medical setup and the high cost of ureteroscope devices are expected to pose a challenge to the ureteroscope market growth.
Ureteroscope Market Segment Analysis:
Ureteroscope Market Product Type (Flexible Ureteroscope [Digital Ureteroscope and Fiber Optic Ureteroscope], Semi-Rigid Ureteroscope), By Channel Type (Dual Channel and Single Channel), By Usability (Single-Use and Reusable), By Application (Urolithiasis, Ureter Transitional Cell Cancer, Urinary Strictures), By End User (Hospitals, Ambulatory Surgical Centers and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Ureteroscope product segment, the flexible ureteroscope is anticipated to hold the largest market share during the forecasted period. This is due to the wide use of the flexible ureteroscope for the treatment of various kidney and ureter stones. Also, flexible ureteroscopy is a latest generation of device when compared to semi rigid ureteroscopy and thus they causes minimum pain and discomfort to the patient with low chances of injury. The advantages of flexible ureteroscopy over semi-rigid ureteroscopy will shift the demand of patients towards flexible ureteroscopy thereby increasing the market for flexible ureteroscope. Moreover, increase in flexible ureteroscopy in hospitals is also a factor driving the market for flexible ureteroscope. For instance, flexible ureteroscope are widely used along with laser lithotripsy in nearly all hospitals by the urologists for better management of urolithiasis with high success rate and low complication rate. Moreover, retrograde flexible ureteroscopy (RFU) has high sensitivity for the diagnosis of urinary tract urothelial carcinomas.
Thus, the above-mentioned factors are expected to drive the flexible ureteroscope market.
North America is expected to dominate the overall Ureteroscope Market:
Among all the regions, North America is expected to dominate the overall ureteroscope market. This domination is owing to the favourable reimbursement scenario, advanced healthcare infrastructure, and well-versed guidelines for the surgical and medical management of the upper tract stone disease in the region is projected to boost the ureteroscope market.
Further, in the United States the rising cases of upper tract urothelial carcinoma (UTUC), is also the reason for increase in usage of ureteroscope. For instance, as per the Centers for Disease Control and Prevention (CDC) 2020 data, approximately 17,500 women and 56,000 men suffer from bladder cancer in the US. Moreover, according to the Canadian cancer society 2020 data, there were around 12,200 Canadians suffered from bladder cancer in the year 2020.
In addition, the launch of new products in the region is likely to propel the market for ureteroscope in the region. For instance, in 2019, Dornier Medtech launched and announced the immediate availability of its new AXIS single-use digital flexible ureteroscope in the US. Thus, these factors are projected to contribute to the ureteroscope market during the forecasted period.
Additionally, the Asia-pacific region has future potential for the ureteroscope market. This is because of the rising number of kidney and bladder cancer in the region. Also, the growing cases of urolithiasis are factors expected to promote the growth of ureteroscope in the region. For instance, as per the GLOBOCAN 2022 data, there were approximately 21,096 and 16,861 cases of bladder and kidney respectively in India in the year 2020. Moreover, improving healthcare infrastructure, growing disposable income in the region could also boost the ureteroscope market.
Ureteroscope Market Key Players:
Some of the key market players operating in the Ureteroscope market include Olympus, Stryker, Boston Scientific Corporation, Richard Wolf GmbH, KARL STORZ, ELMED Medical Systems, PENTAX Medical, OPCOM, Dornier Medtech, Maxer Endoscopy GmbH, Vimex Sp. z o. o., AED.MD, NeoScope Inc., Advin Health Care, OTU Medical., Clarion Medical Technologies., Zhuhai Mindhao Medical Technology Co., Ltd., Innovex Medical Co., Ltd., Biorad Medisys Pvt Ltd., Shanghai SeeGen Photoelectric Technology Co., Ltd., and others.
Recent Developmental Activities in the Ureteroscope Market:
In August 2020, Olympus Winter & Ibe GmbH received the US FDA approval for OES Elite Ureteroscopes and Accessories under regulatory class II for endoscopic observation and therapy in the ureters, urethra, and urinary bladder.
Key Takeaways from the Ureteroscope Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyse suitable indicators, our experts are closely watching the Ureteroscope market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Ureteroscope Market.
Various opportunities available for the other competitor in the Ureteroscope Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Ureteroscope market growth in the coming future?
Target Audience Who Can Be Benefited from the Ureteroscope Market Report Study
Ureteroscope providers
Research organizations and consulting companies
Ureteroscope-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Ureteroscope
Various End-users who want to know more about the Ureteroscope Market and latest technological developments in the Ureteroscope market.
Frequently Asked Questions for the Ureteroscope Market:
Ureteroscope is a small flexible telescope that is inserted into the bladder and ureter to diagnose and treat a variety of problems associated with the urinary tract.
The global ureteroscope market was valued at USD 0.90 billion in 2023, growing at a CAGR of 5.49% during the forecast period from 2024 to 2030, to reach USD 1.24 billion by 2030.
The major factors driving the demand for Ureteroscope are the rising cases of urolithiasis, increase in demand for minimally invasive procedures for kidney stone management, rising sedentary lifestyle, among others. In addition, new product launch and technological advancement in the ureteroscope product portfolio is also expected to augment the market.
Some of the key market players operating in the Ureteroscope market include Olympus, Stryker, Boston Scientific Corporation, Richard Wolf GmbH, KARL STORZ, ELMED Medical Systems, PENTAX Medical, OPCOM, Dornier Medtech, Maxer Endoscopy GmbH, Vimex Sp. z o. o., AED.MD, NeoScope Inc., Advin Health Care, OTU Medical., Clarion Medical Technologies., Zhuhai Mindhao Medical Technology Co., Ltd., Innovex Medical Co., Ltd., Biorad Medisys Pvt Ltd., Shanghai SeeGen Photoelectric Technology Co., Ltd., and others.
Among all the regions, North America is expected to dominate the overall ureteroscope market during the forecasted period, 2024-2030. This domination is owing to the favorable reimbursement scenario, advanced healthcare infrastructure, and well-versed guidelines for the surgical and medical management of the upper tract stone disease in the region is projected to boost the ureteroscope market.